438 related articles for article (PubMed ID: 24924587)
1. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
[TBL] [Abstract][Full Text] [Related]
2. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
3. Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
Groenveld HF; Tijssen JG; Crijns HJ; Van den Berg MP; Hillege HL; Alings M; Van Veldhuisen DJ; Van Gelder IC;
J Am Coll Cardiol; 2013 Feb; 61(7):741-8. PubMed ID: 23410544
[TBL] [Abstract][Full Text] [Related]
4. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy.
Badheka AO; Shah N; Grover PM; Patel NJ; Chothani A; Mehta K; Singh V; Deshmukh A; Savani GT; Rathod A; Panaich SS; Patel N; Arora S; Bhalara V; Coffey JO; Mitrani RD; Halperin JL; Viles-Gonzalez JF
Am J Cardiol; 2014 Apr; 113(7):1159-65. PubMed ID: 24507168
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
[TBL] [Abstract][Full Text] [Related]
7. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
Freeman JV; Reynolds K; Fang M; Udaltsova N; Steimle A; Pomernacki NK; Borowsky LH; Harrison TN; Singer DE; Go AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
[TBL] [Abstract][Full Text] [Related]
8. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
[TBL] [Abstract][Full Text] [Related]
9. Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.
Smit MD; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Tuininga YS; Groenveld HF; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC;
J Am Coll Cardiol; 2011 Aug; 58(9):942-9. PubMed ID: 21851883
[TBL] [Abstract][Full Text] [Related]
10. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
[TBL] [Abstract][Full Text] [Related]
11. Lenient versus strict rate control in patients with atrial fibrillation.
Van Gelder IC; Groenveld HF; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Hillege HL; Bergsma-Kadijk JA; Cornel JH; Kamp O; Tukkie R; Bosker HA; Van Veldhuisen DJ; Van den Berg MP;
N Engl J Med; 2010 Apr; 362(15):1363-73. PubMed ID: 20231232
[TBL] [Abstract][Full Text] [Related]
12. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
[TBL] [Abstract][Full Text] [Related]
13. Rate-control treatment and mortality in atrial fibrillation.
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
[TBL] [Abstract][Full Text] [Related]
14. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
[TBL] [Abstract][Full Text] [Related]
15. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
16. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
Friberg L; Hammar N; Rosenqvist M
Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
[TBL] [Abstract][Full Text] [Related]
17. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
[TBL] [Abstract][Full Text] [Related]
18. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Groenveld HF; Van den Berg MP; Van Gelder IC;
Eur J Heart Fail; 2013 Nov; 15(11):1311-8. PubMed ID: 23759284
[TBL] [Abstract][Full Text] [Related]
19. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
[No Abstract] [Full Text] [Related]
20. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
